Healthcare -
Biotechnology - NASDAQ - GB
$ 1.38
0.362 %
$ 56.7 M
Market Cap
-0.83
P/E
Price Target
Average
44.93%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
1.22%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Achilles Therapeutics plc
Wall Street analysts predict an average 1-year price target for ACHL of $2 , with forecasts ranging from
a
low of
$2 to a high of $2 .
ACHL Lowest Price Target
Wall Street Target
2 USD
44.93%
ACHL Average Price Target
Wall Street Target
2 USD
44.93%
ACHL Highest Price Target
Wall Street Target
2 USD
44.93%
REVENUE FORECAST
Revenue Forecast Chart ACHL
EBIT FORECAST
EBIT Forecast Chart ACHL
NET INCOME FORECAST
Net Income Chart ACHL